Skip to main content

Contractor intelligence · computed from public award records

MEDIPHARMA S.A.

Awards won
12
Known value
USD 4.1M
First award
06 May 2003
Most recent
27 Dec 2013

Wins by funder

FunderAwardsKnown valueMost recent
Inter-American Development Bank7USD 3.6M27 Dec 2013
World Bank5USD 492K12 May 2008

Where the work is

AR · 7

Sources

The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.

  • Strenghtening the Basic Health Care Strategy (FEAPS) · 27 Dec 2013 · USD 205K · Inter-American Development Bank
  • Multiphase Primary Health Care Program for Managing Chronic Non-communicable Dis · 18 Sept 2012 · USD 83K · Inter-American Development Bank
  • Strenghtening the Basic Health Care Strategy (FEAPS) · 18 Sept 2012 · USD 1.2M · Inter-American Development Bank
  • Strenghtening the Basic Health Care Strategy (FEAPS) · 18 Sept 2012 · USD 1.2M · Inter-American Development Bank
  • Strenghtening the Basic Health Care Strategy (FEAPS) · 09 Aug 2011 · USD 525K · Inter-American Development Bank
  • Strenghtening the Basic Health Care Strategy (FEAPS) · 26 Jul 2010 · USD 188K · Inter-American Development Bank
  • Strenghtening the Basic Health Care Strategy (FEAPS) · 14 Jan 2010 · USD 238K · Inter-American Development Bank
  • 5000 CONTAINERS WITH 100 DESINFECTANT EFERVESCENT PILLS · 12 May 2008 · USD 76K · World Bank
  • ARV DRUG: LOT. 21: STAVUDINA (CAPSULES 30 MG EA.)= 1,444,334 UNITS & LOT 22:STAVUDINA (CAPSULES 30 MG EA.)=2,217,094 UNITS · 11 Dec 2003 · USD 191K · World Bank
  • STAVUDINA COMPRIMIDOS 30 MG. BY MEDIPHARMA · 06 May 2003 · USD 25K · World Bank
  • STAVUDINA COMPRIMIDOS 40 MG. BY MEDIPHARMA S,A · 06 May 2003 · USD 130K · World Bank
  • ZALCITABINA COMPRIMIDOS BY MEDIPHARMA S.A · 06 May 2003 · USD 70K · World Bank

Method

Computed from 12 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.